𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha

✍ Scribed by Osman Elbek; Meral Uyar; Neriman Aydın; Şermin Börekçi; Nazan Bayram; Hasan Bayram; Öner Dikensoy

Publisher
Springer
Year
2008
Tongue
English
Weight
122 KB
Volume
28
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased risk of coccidioidomycosis in
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
✍ Laurie Bergstrom; David E. Yocum; Neil M. Ampel; Isidro Villanueva; Jeffrey Liss 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objective To describe a group of patients who were treated with tumor necrosis factor α (TNFα) antagonists and who developed coccidioidomycosis, and to test the hypothesis that patients with inflammatory arthritis receiving TNFα antagonist therapy are at higher risk for developing s

Presentation and outcome of histoplasmos
Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series
✍ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection